title: BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment.
authors.affiliation: St. Anna Kinderspital, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Ladenstein
authors.forename: C
authors.initials: C
authors.lastname: Peters
authors.forename: S
authors.initials: S
authors.lastname: Matthes-Martin
authors.forename: A
authors.initials: A
authors.lastname: Rosenmayr
authors.forename: P
authors.initials: P
authors.lastname: Höcker
authors.forename: R
authors.initials: R
authors.lastname: Pötter
authors.forename: U
authors.initials: U
authors.lastname: Pötschinger
authors.forename: H
authors.initials: H
authors.lastname: Gadner
mesh_terms: D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy*; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D014019:Tissue Donors; D014184:Transplantation, Homologous